Source: Stocksy Copyright: ZHPH Production URL: Licensed by the authors   Results illustrate the promise of psychiatric care via a telehealth platform to address suicidal ideation, highlighting the efficacy of Brightside Health’s care model and approach to precision prescribing. SAN FRANCISCO, CA—September 30, 2022: Brightside Health, a telemedicine platform that offers timely access to personalized treatment, expert providers, and ongoing support for a range of mental health concerns, announced today the publication of a study to examine the impact of a telepsychiatric care platform on reduction in suicidal ideation (SI) over time. The peer-reviewed research, “Telehealth-Supported Decision-making Psychiatric Care for Suicidal Ideation: Longitudinal ObservationalRead More →

Source: iStock/Constant Therapy Copyright: iStock/Constant Therapy URL: License info: Creative Commons Attribution (CC-BY) Study Evaluated the Feasibility of Long-term Home-Based Digital Cognitive Therapy for Patients With Alzheimer Disease With Mild Cognitive Impairment and Mild Dementia LEXINGTON, Mass. – September 12, 2022 – Constant Therapy Health, a brain health digital therapeutics company, announced today the publication of a feasibility study of its Constant Therapy digital cognitive therapy platform in JMIR Formative Research, titled, “Home-Based Electronic Cognitive Therapy in Patients With Alzheimer Disease: Feasibility Randomized Controlled Trial.” The study, conducted by the Alzheimer’s Disease Research Center and Department of Behavioral Neuroscience at Boston University School of Medicine, in collaborationRead More →